We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
- Authors
Hadji, P; Kauka, A; Ziller, M; Birkholz, K; Baier, M; Muth, M; Bauer, M
- Abstract
The effects of bisphosphonates on altered bone turnover marker (BTM) levels associated with adjuvant endocrine or chemotherapy in early breast cancer have not been systematically investigated. In ProBONE II, zoledronic acid decreased these elevated BTM levels and increased bone mineral density (BMD) during adjuvant therapy, consistent with its antiresorptive effects.
- Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Vol 25, Issue 4, p1369
- ISSN
1433-2965
- Publication type
Journal Article
- DOI
10.1007/s00198-013-2615-z